PharmiWeb.com - Global Pharma News & Resources

Heidelberg Pharma

Pharmaco

Heidelberg Pharma focuses on oncology and is the first company to use and develop the active ingredient Amanitin for cancer therapies. To do this, the company uses its innovative ATAC technology (Antibody Targeted Amanitin Conjugates) and uses the toxin's biological mechanism of action as a new therapeutic principle.